NEO
Price
$7.97
Change
+$0.11 (+1.40%)
Updated
Sep 26, 04:38 PM (EDT)
Capitalization
1.02B
46 days until earnings call
RGEN
Price
$125.63
Change
+$3.95 (+3.25%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
6.85B
39 days until earnings call
Interact to see
Advertisement

NEO vs RGEN

Header iconNEO vs RGEN Comparison
Open Charts NEO vs RGENBanner chart's image
NeoGenomics
Price$7.97
Change+$0.11 (+1.40%)
Volume$500
Capitalization1.02B
Repligen
Price$125.63
Change+$3.95 (+3.25%)
Volume$7.59K
Capitalization6.85B
NEO vs RGEN Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. RGEN commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and RGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (NEO: $7.86 vs. RGEN: $121.68)
Brand notoriety: NEO and RGEN are both not notable
NEO represents the Medical Specialties, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NEO: 41% vs. RGEN: 72%
Market capitalization -- NEO: $1.02B vs. RGEN: $6.85B
NEO [@Medical Specialties] is valued at $1.02B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.85B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.33B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 6 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 6 bearish.
  • RGEN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than NEO.

Price Growth

NEO (@Medical Specialties) experienced а -8.76% price change this week, while RGEN (@Pharmaceuticals: Other) price change was -2.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.07%. For the same industry, the average monthly price growth was +4.09%, and the average quarterly price growth was +25.78%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (-0.07% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($6.85B) has a higher market cap than NEO($1.02B). RGEN YTD gains are higher at: -15.465 vs. NEO (-52.275). RGEN has higher annual earnings (EBITDA): 99.5M vs. NEO (-28.47M). RGEN has more cash in the bank: 709M vs. NEO (164M). NEO has less debt than RGEN: NEO (412M) vs RGEN (686M). NEO (689M) and RGEN (674M) have equivalent revenues.
NEORGENNEO / RGEN
Capitalization1.02B6.85B15%
EBITDA-28.47M99.5M-29%
Gain YTD-52.275-15.465338%
P/E RatioN/A521.44-
Revenue689M674M102%
Total Cash164M709M23%
Total Debt412M686M60%
FUNDAMENTALS RATINGS
NEO vs RGEN: Fundamental Ratings
NEO
RGEN
OUTLOOK RATING
1..100
7210
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
5560
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
2350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (65) in the Medical Or Nursing Services industry is in the same range as RGEN (95) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as RGEN (100) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's SMR Rating (92) in the Biotechnology industry is in the same range as NEO (95) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (55) in the Medical Or Nursing Services industry is in the same range as RGEN (60) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEORGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MERDX34.21N/A
N/A
Meridian Growth Legacy
WBBIX10.60N/A
N/A
TETON Westwood Balanced I
MLPTX9.79N/A
N/A
Invesco SteelPath MLP Select 40 Y
TEQKX13.70-0.06
-0.44%
Nuveen Emerging Markets Eq Idx A
MPITX16.61-0.13
-0.78%
BNY Mellon International M

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-0.06%
RGEN - NEO
38%
Loosely correlated
-2.27%
VCYT - NEO
38%
Loosely correlated
+0.43%
FLGT - NEO
37%
Loosely correlated
-0.32%
NNOX - NEO
36%
Loosely correlated
-4.80%
TWST - NEO
35%
Loosely correlated
-1.00%
More